A Dimitrios Colevas

9PUBLICATIONS
81CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 10, 2026
Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma: CSCO and ASCO Joint Guideline.

|Nov 10, 2026
Treatment of Stage IB to III Nasopharyngeal Carcinoma: CSCO-ASCO Guideline Update.

|May 13, 2026
Mitochondrial Imaging Detects Early Cardiac Changes Following Cancer Immunotherapy.

|May 28, 2025
Update: Immunotherapeutic Strategies in HPV-Associated Head and Neck Squamous Cell Carcinoma.

Fangdi Sun, A Dimitrios Colevas

|Jan 20, 2025
First-in-Human Clinical Trial of a Small-Molecule EBNA1 Inhibitor, VK-2019, in Patients with Epstein-Barr-Positive Nasopharyngeal Cancer, with Pharmacokinetic and Pharmacodynamic Studies.

A Dimitrios Colevas, Zahra Talebi, Elizabeth Winters

|Feb 02, 2023
In search for optimal induction chemotherapy for advanced nasopharyngeal cancer: Standard dosing of Docetaxel, Platinum, and 5-Fluorouracil (TPF) followed by chemoradiation.

Michelle Jun, Harlan Pinto, Quynh-Thu Le

Pageof 2

Frequent Collaborators

3 joint publications

Quynh-Thu Le

2 joint publications

Nofisat Ismaila

2 joint publications

Melvin Lk Chua

2 joint publications

Brigette Ma